Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Monsanto Co. -- Ignore unavailable to you. Want to Upgrade?

To: jopawa who wrote (831)	1/5/1999 9:09:00 AM
From: TheSlowLane	Read Replies (2) \| Respond to of 2539

I understand that MTC will be pricing Celebrex aggresively, so that the daily cost would be between $2-$3 a day. That should help keep the insurance companies calm. Also, I think it is an excellent pre-emptive strike to grab market share. Instead of exploiting their small window of opportunity and charging big bucks, they are going for numbers and that is the right thing to do for the long term. Once people have started using Celebrex, why would they switch to anything else (especially a drug that has a name that sounds like an STD). I think we're about to see the Clairol effect in action within a few weeks. I'm excited.